Gaucher Disease Patient With Myoclonus Epilepsy and a Novel Mutation

被引:4
|
作者
Tajima, Asako [1 ]
Ohashi, Toya [2 ]
Hamano, Shin-ichiro [3 ]
Higurashi, Norimichi [3 ]
Ida, Hiroyuki
机构
[1] Jikei Univ, Sch Med, Dept Pediat, Inst DNA Med,Minato Ku, Tokyo 1058461, Japan
[2] Jikei Univ, Sch Med, Inst DNA Med, Dept Gene Therapy, Tokyo 1058461, Japan
[3] Saitama Childrens Med Ctr, Div Neurol, Saitama, Japan
关键词
IDENTIFICATION;
D O I
10.1016/j.pediatrneurol.2009.08.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The N188S mutation in Gaucher disease is associated with myoclonus epilepsy. We performed genetic analysis on a patient with progressive myoclonus epilepsy, who had received antiepileptic drugs for over 10 years. We detected N188S/G199D on the gene encoding glucocerebrosidase. Mutant proteins carrying each mutation were expressed in COS-1 cells (a commonly used cell line which derives from kidney cells of the African green monkey). Measurements of enzymatic activity and Western blotting analysis were performed. When residual activities were measured, glucocerebrosidase with the N188S mutation exhibited 50% activity of the wild type, and with G199D, 7.4%. Neither mutation influenced the stability of the enzyme protein. These data suggested a diagnosis of Gaucher disease for this patient, and indicated that G199D is a novel mutation. (C) 2010 by Elsevier Inc. All rights reserved.
引用
收藏
页码:65 / 68
页数:4
相关论文
共 50 条
  • [1] Myoclonus in Gaucher disease
    Frei, KP
    Schiffmann, R
    MYOCLONUS AND PAROXYSMAL DYSKINESIAS, 2002, 89 : 41 - 48
  • [2] A novel exon 3 mutation in a Tunisian patient with Lafora's progressive myoclonus epilepsy
    Mrabet, H.
    Mrabet, A.
    Malafosse, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 604 - 604
  • [3] A NOVEL ASPARTYLGLUCOSAMINURIA MUTATION IN A PATIENT WITH CO-EXISTENCE OF GAUCHER DISEASE
    Kiykim, E.
    Zubarioglu, T.
    Gorukmez, O.
    Gunev, S.
    Cansever, M. S.
    Zeybek, A. C. Aktuglu
    GENETIC COUNSELING, 2015, 26 (04): : 463 - 466
  • [4] Progressive myoclonus epilepsy in Gaucher Disease due to a new Gly–Gly mutation causing loss of an Exonic Splicing Enhancer
    Rodolfo Tonin
    Serena Catarzi
    Anna Caciotti
    Elena Procopio
    Carla Marini
    Renzo Guerrini
    Amelia Morrone
    Journal of Neurology, 2019, 266 : 92 - 101
  • [5] Eye closure-induced seizures in Gaucher disease and progressive myoclonus epilepsy
    Serrao, Catarina
    Aldomiro, Alexandre
    Parreira, Sara
    Franco, Ana
    Guedes, Leonor Correia
    Bentes, Carla
    Peralta, Ana Rita
    EPILEPTIC DISORDERS, 2024, 26 (06) : 895 - 897
  • [6] Progressive myoclonus epilepsy in Gaucher Disease due to a new Gly-Gly mutation causing loss of an Exonic Splicing Enhancer
    Tonin, Rodolfo
    Catarzi, Serena
    Caciotti, Anna
    Procopio, Elena
    Marini, Carla
    Guerrini, Renzo
    Morrone, Amelia
    JOURNAL OF NEUROLOGY, 2019, 266 (01) : 92 - 101
  • [7] Long-term efficacy of low-dose perampanel for progressive myoclonus epilepsy in a patient with Gaucher disease type 3
    Tahara, Mayu
    Higurashi, Norimichi
    Narita, Aya
    Ida, Hiroyuki
    BRAIN & DEVELOPMENT, 2022, 44 (04): : 308 - 312
  • [8] Novel cystatin B mutation and diagnostic PCR assay in an Unverricht-Lundborg progressive myoclonus epilepsy patient
    Bespalova, IN
    Adkins, S
    Pranzatelli, M
    Burmeister, M
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (05): : 467 - 471
  • [9] Novel insertion mutation in a non-Jewish Caucasian type 1 Gaucher disease patient
    Choy, FYM
    Humphries, ML
    Ferreira, P
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 68 (02): : 211 - 215
  • [10] Gaucher type 2 disease: Identification of a novel transversion mutation in a French-Irish patient
    Choy, FYM
    Humphries, ML
    Ben-Yoseph, Y
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 78 (01): : 92 - 93